tiprankstipranks
Advertisement
Advertisement
Glaukos price target raised to $195 from $165 at Piper Sandler
PremiumThe FlyGlaukos price target raised to $195 from $165 at Piper Sandler
14h ago
Glaukos price target raised to $188 from $175 at Citi
Premium
The Fly
Glaukos price target raised to $188 from $175 at Citi
14h ago
Glaukos price target raised to $178 from $138 at Wells Fargo
Premium
The Fly
Glaukos price target raised to $178 from $138 at Wells Fargo
14h ago
Glaukos reports Q2 adjusted EPS (14c), consensus (21c)
PremiumThe FlyGlaukos reports Q2 adjusted EPS (14c), consensus (21c)
1d ago
Glaukos assumed with Neutral from Buy at UBS
Premium
The Fly
Glaukos assumed with Neutral from Buy at UBS
3d ago
Glaukos completes patient enrollment in 510k study for PRESERFLO
Premium
The Fly
Glaukos completes patient enrollment in 510k study for PRESERFLO
4d ago
Glaukos price target raised to $175 from $162 at Citi
PremiumThe FlyGlaukos price target raised to $175 from $162 at Citi
23d ago
Glaukos: Favorable iDose Reimbursement Outlook and Epioxa Launch Drive Attractive Risk-Reward, Supporting Buy Rating
Premium
Ratings
Glaukos: Favorable iDose Reimbursement Outlook and Epioxa Launch Drive Attractive Risk-Reward, Supporting Buy Rating
23d ago
Okta upgraded, Datadog downgraded: Wall Street’s top analyst calls
Premium
The Fly
Okta upgraded, Datadog downgraded: Wall Street’s top analyst calls
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100